We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,615 results
  1. What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study

    Background

    The impact of blood pressure on neurological symptoms and risk of end-stage kidney disease (ESKD) is unknown in primary and secondary...

    Jean-Michel Halimi, Benjamin Thoreau, ... Fadi Fakhouri in BMC Nephrology
    Article Open access 20 January 2022
  2. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

    Pleural mesothelioma (PM) is an aggressive malignancy with poor prognosis. Although histology and pathologic stage are important prognostic factors,...

    Jan Hendrik Rüschoff, Martina Haberecker, ... Jan von der Thüsen in Modern Pathology
    Article Open access 17 September 2022
  3. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy

    Background

    Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy (TMA) requiring urgent treatment....

    I. Mancini, P. Agosti, ... Pagani Ambrogio in Orphanet Journal of Rare Diseases
    Article Open access 23 June 2022
  4. Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment

    The past decade has witnessed ongoing progress in immune therapy to ameliorate human health. As an emerging technique, chimeric antigen receptor...

    Ting Yan, Lingfeng Zhu, ** Chen in Experimental Hematology & Oncology
    Article Open access 27 January 2023
  5. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.

    Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. CRC liver metastases (CRLM) are often resistant to...

    Celine Man Ying Li, Matthew T. Briggs, ... Kevin Fenix in Clinical and Experimental Medicine
    Article Open access 16 March 2024
  6. Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology

    Background

    Thrombotic microangiopathies (TMAs) are rare but can be severe in kidney transplant.

    recipients (KTR).

    Methods

    We analysed the epidemiology...

    Florent Von Tokarski, Alexandre Fillon, ... Jean-Michel Halimi in BMC Nephrology
    Article Open access 20 September 2023
  7. Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific Survival

    Introduction

    Breast cancer in older women tends to have more favourable biology, compared to younger women. Androgen receptor (AR) is significant for...

    Jahnavi Kalvala, Ruth M. Parks, ... Kwok-Leung Cheung in Advances in Therapy
    Article 28 April 2023
  8. Correlation of RANK and RANKL with mammographic density in primary breast cancer patients

    Purpose

    The receptor activator of nuclear factor kappa B (RANK) and its ligand (RANKL) have been shown to promote proliferation of the breast and...

    Marius Wunderle, Felix Heindl, ... Julius Emons in Archives of Gynecology and Obstetrics
    Article Open access 05 June 2024
  9. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms

    Hand2 is a core transcription factor responsible for chromaffin cell differentiation. However, its potential utility in surgical pathology has not...

    Jiri Soukup, Monika Manethova, ... Filip Gabalec in Endocrine Pathology
    Article 28 February 2024
  10. Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors

    Preferentially expressed antigen of melanoma (PRAME) is a cancer/testis antigen selectively expressed in somatic tissues and various solid malignant...

    Adam Šafanda, Michaela Kendall Bártů, ... Kristýna Němejcová in Virchows Archiv
    Article 23 August 2023
  11. Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer

    The impact of tumor focality on prostate cancer (PCa) prognosis has been addressed in several studies with conflicting results. Tumor foci from...

    Laura Segalés, Nuria Juanpere, ... Silvia Hernández-Llodrà in Virchows Archiv
    Article Open access 28 November 2023
  12. The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis

    Purpose

    Ubiquitin-conjugating enzyme E2 C (UBE2C) is known to show a causal relationship with cancer development and advancement. The role of UBE2C is...

    Jae Heon Kim, Kwang Woo Lee, ... Yun Seob Song in Journal of Cancer Research and Clinical Oncology
    Article 08 February 2023
  13. Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release

    Cancer-associated fibroblasts (CAFs), the principal constituent of the heterogenous tumor microenvironment, have been shown to promote tumor...

    Chanjun Sun, Kaishang Zhang, ... Zhihai Qin in Oncogenesis
    Article Open access 29 March 2023
  14. Protein-based immune profiles of basal-like vs. luminal breast cancers

    Tumor-infiltrating lymphocytes play an important, but incompletely understood role in chemotherapy response and prognosis. In breast cancer, there...

    Andrea Walens, Linnea T. Olsson, ... Benjamin C. Calhoun in Laboratory Investigation
    Article 23 February 2021
  15. Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours

    Non-ossifying fibroma (NOF) and central giant cell granuloma (CGCG) are both benign tumours of bone with overlap** morphology and similar mutations...

    Arjen H. G. Cleven, Willem H. Schreuder, ... Judith V. M. G. Bovée in Virchows Archiv
    Article Open access 25 May 2022
  16. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands

    Molecular analysis has allowed for refinement of salivary gland tumor classification and, in some cases, the recognition of entirely new tumor types....

    Justin A. Bishop, Prasad Koduru, ... Elizabeth G. Demicco in Head and Neck Pathology
    Article 04 January 2021
  17. Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs

    Interleukin-1 alpha (IL-1α) is a cytokine involved in the acute phase immune response and its expression is upregulated in a variety of solid tumors...

    Ishrat Nourin Khan, Katherine N. Gibson-Corley, ... Andrean L. Simons in Head and Neck Pathology
    Article 25 March 2022
  18. Presence of Epstein–Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma

    EBV+ diffuse large B cell lymphoma (DLBCL) not otherwise specified (NOS) is a new entity confirmed by the World Health Organization (WHO) in 2017. In...

    T. Mangiaterra, R. Alonso-Alonso, ... P. Chabay in Cancer Immunology, Immunotherapy
    Article Open access 27 January 2024
  19. Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations

    Colorectal cancer (CRC) has one of the highest cancer incidences and mortality rates. In stage III, postoperative chemotherapy benefits <20% of...

    Xanthi Stachtea, Maurice B. Loughrey, ... Daniel B. Longley in Modern Pathology
    Article Open access 03 November 2021
  20. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development

    Background

    Lymphovascular invasion (LVI) is regulated through complex molecular mechanisms. Cyclin B1 ( CCNB1 ) was previously determined as being...

    Abrar I. Aljohani, Michael S. Toss, ... Emad A. Rakha in Breast Cancer Research and Treatment
    Article Open access 22 November 2022
Did you find what you were looking for? Share feedback.